ISSN: 2155-9570
+44 1223 790975
Martin K Schmid, Michael A Thiel, Lucas M Bachmann and Reinier O Schlingemann
The discovery of anti-VEGF drugs has revolutionized the management of age-related macular degeneration, diabetic macular oedema and retinal vein occlusion. This paper discusses how the management evolved in the anti- VEGF era, addresses salient yet unresolved aspects of early identification and monitoring but also takes notice of challenges associated with long term care. The paper proposes to increase the role of patient self-management, as this has been shown to be effective in many other chronic clinical conditions, and sets out the requirements making self-management operational.